oleanolic acid has been researched along with Subarachnoid Hemorrhage in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (40.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 2 (40.00) | 2.80 |
Authors | Studies |
---|---|
Han, Y; Li, X; Liang, G; Wang, C | 1 |
Han, Y; Li, X; Liang, G; Tong, Z; Wang, C | 1 |
Han, YW; Li, XM; Liu, XJ; Zhao, Y | 1 |
Fujimoto, M; Hiramatsu, K; Kita, T; Kubo, K; Nakashima, T; Sakaki, T; Sato, S; Yonetani, Y | 1 |
Kita, T; Kubo, K; Momochi, C; Nakashima, T; Narushima, I; Shimada, K; Yonetani, Y; Yoshikawa, I | 1 |
5 other study(ies) available for oleanolic acid and Subarachnoid Hemorrhage
Article | Year |
---|---|
Oleanolic acid reduces oxidative stress and neuronal apoptosis after experimental subarachnoid hemorrhage by regulating Nrf2/HO-1 pathway.
Topics: Animals; Antioxidants; Apoptosis; Heme Oxygenase (Decyclizing); Neuroprotective Agents; NF-E2-Related Factor 2; Oleanolic Acid; Oxidative Stress; Rats; Rats, Sprague-Dawley; Subarachnoid Hemorrhage | 2022 |
Oleanolic acid exerts neuroprotective effects in subarachnoid hemorrhage rats through SIRT1-mediated HMGB1 deacetylation.
Topics: Acetylation; Animals; Anti-Inflammatory Agents; Apoptosis; Blood-Brain Barrier; Brain; Brain Edema; Capillary Permeability; Disease Models, Animal; HMGB1 Protein; Male; Neuroprotective Agents; Oleanolic Acid; Protein Processing, Post-Translational; Rats, Sprague-Dawley; Signal Transduction; Sirtuin 1; Subarachnoid Hemorrhage | 2021 |
Role of Oleanolic acid in maintaining BBB integrity by targeting p38MAPK/VEGF/Src signaling pathway in rat model of subarachnoid hemorrhage.
Topics: Animals; Blood-Brain Barrier; Body Weight; Disease Models, Animal; Gene Expression Regulation; Heme Oxygenase-1; Male; MAP Kinase Signaling System; Microglia; Oleanolic Acid; p38 Mitogen-Activated Protein Kinases; Permeability; Rats; Rats, Sprague-Dawley; src-Family Kinases; Subarachnoid Hemorrhage; Vascular Endothelial Growth Factor A | 2018 |
Profiles of an intravenously available endothelin A-receptor antagonist, S-0139, for preventing cerebral vasospasm in a canine two-hemorrhage model.
Topics: Animals; Basilar Artery; Caffeic Acids; Disease Models, Animal; Dogs; Endothelin Receptor Antagonists; Female; Infusions, Intravenous; Ischemic Attack, Transient; Male; Oleanolic Acid; Spine; Subarachnoid Hemorrhage | 1998 |
Contribution of endothelin-1 to disruption of blood-brain barrier permeability in dogs.
Topics: Analysis of Variance; Animals; Blood; Blood-Brain Barrier; Caffeic Acids; Cell Membrane Permeability; Cisterna Magna; Disease Models, Animal; Dogs; Dose-Response Relationship, Drug; Endothelin Receptor Antagonists; Endothelin-1; Female; Fluorescein; Injections, Intraventricular; Male; Oleanolic Acid; Receptor, Endothelin A; Subarachnoid Hemorrhage | 1999 |